538 related articles for article (PubMed ID: 27266406)
1. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
[TBL] [Abstract][Full Text] [Related]
2. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
[TBL] [Abstract][Full Text] [Related]
3. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
[TBL] [Abstract][Full Text] [Related]
4. Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis.
Ruskin O; Sanelli A; Herschtal A; Webb A; Dixon B; Pohl M; Donahoe S; Spillane J; Henderson MA; Gyorki DE
Head Neck; 2016 Sep; 38(9):1373-9. PubMed ID: 27014970
[TBL] [Abstract][Full Text] [Related]
5. Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.
Lee DY; Huynh KT; Teng A; Lau BJ; Vitug S; Lee JH; Stern SL; Foshag LJ; Faries MB
Ann Surg Oncol; 2016 Mar; 23(3):1012-8. PubMed ID: 26586498
[TBL] [Abstract][Full Text] [Related]
6. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
7. The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival.
Fortes C; Mastroeni S; Caggiati A; Passarelli F; Zappalà A; Capuano M; Bono R; Nudo M; Marino C; Michelozzi P
Am J Surg; 2016 Nov; 212(5):935-940. PubMed ID: 27266393
[TBL] [Abstract][Full Text] [Related]
8. Incomplete sentinel node biopsy is not clearly related to survival or regional recurrence in cutaneous melanoma patients.
Lee NC; Spillane AJ; Pang TC; Haydu LE; Uren RF
Ann Surg Oncol; 2012 Jan; 19(1):280-6. PubMed ID: 21833669
[TBL] [Abstract][Full Text] [Related]
9. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.
van der Ploeg AP; Haydu LE; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF; Scolyer RA; Thompson JF
Ann Surg; 2014 Jul; 260(1):149-57. PubMed ID: 24633018
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.
Belgrano V; Katsarelias D; Mattsson J; Olofsson Bagge R
Eur J Surg Oncol; 2019 Feb; 45(2):225-230. PubMed ID: 30391091
[TBL] [Abstract][Full Text] [Related]
11. Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.
Tejera-Vaquerizo A; Nagore E; Puig S; Robert C; Saiag P; Martín-Cuevas P; Gallego E; Herrera-Acosta E; Aguilera J; Malvehy J; Carrera C; Cavalcanti A; Rull R; Vilalta-Solsona A; Lannoy E; Boutros C; Benannoune N; Tomasic G; Aegerte P; Vidal-Sicart S; Palou J; Alos LL; Requena C; Traves V; Pla Á; Bolumar I; Soriano V; Guillén C; Herrera-Ceballos E
Eur J Cancer; 2015 Sep; 51(13):1780-93. PubMed ID: 26072362
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy is prognostic but not therapeutic for thick melanoma.
Kachare SD; Singla P; Vohra NA; Zervos EE; Wong JH; Fitzgerald TL
Surgery; 2015 Sep; 158(3):662-8. PubMed ID: 26096561
[TBL] [Abstract][Full Text] [Related]
14. Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.
van Lanschot CG; Koljenović S; Grunhagen DJ; Verhoef C; van Akkooi AC
Melanoma Res; 2014 Jun; 24(3):261-6. PubMed ID: 24608184
[TBL] [Abstract][Full Text] [Related]
15. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
16. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
18. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
Baum C; Weiss C; Gebhardt C; Utikal J; Marx A; Koenen W; Géraud C
Int J Cancer; 2017 Apr; 140(8):1907-1917. PubMed ID: 27935036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
